Valuation: Stryker Corporation

Market Cap 120B 105B 97.09B 90.47B 171B 11,422B 174B 1,168B 452B 5,607B 451B 441B 19,513B P/E 2026 *
24.7x
P/E 2027 * 21.6x
Enterprise Value 129B 113B 104B 97.12B 183B 12,261B 187B 1,254B 486B 6,019B 484B 474B 20,946B EV / Sales 2026 *
4.73x
EV / Sales 2027 * 4.25x
Free-Float
94.62%
Yield 2026 *
1.15%
Yield 2027 * 1.23%
1 day+0.37%
1 week+0.53%
Current month+0.98%
1 month+4.69%
3 months-3.95%
6 months-10.35%
Current year-10.35%
1 week 309.86
Extreme 309.86
340
1 month 289
Extreme 289
340
Current year 281.04
Extreme 281.04
389.55
1 year 281.04
Extreme 281.04
405.83
3 years 250.79
Extreme 250.79
406.7
5 years 191.18
Extreme 191.18
406.7
10 years 127.68
Extreme 127.6758
406.7
Manager TitleAgeSince
Chief Executive Officer 60 01/10/2012
Director of Finance/CFO 50 01/04/2025
President 49 01/01/2026
Director TitleAgeSince
Director/Board Member 82 01/01/1974
Director/Board Member 71 01/01/1984
Chairman 60 22/07/2014
Change 5-day change 1-year change 3-year change Capi.($)
+0.37%+0.53% - - 120B
+0.18%-4.41%-0.86%-8.33% 12.33B
-1.57%-0.14%+34.19%+93.19% 8.08B
+3.39%+2.33%-47.97%-71.63% 4B
+2.37%+0.94%+16.83%+37.61% 2.57B
+2.95%+5.16%-10.98%-13.42% 1.86B
+2.50%+1.70%-4.87%-24.74% 1.62B
+0.33%-3.72%+232.84%+162.52% 1.58B
+1.91%+5.23%-65.25%-86.00% 1.31B
Average +1.38%+1.76%+19.24%+11.15% 4.17B
Weighted average by Cap. +0.43%-0.01%+11.11%+16.16%

Financials

2026 *2027 *
Net sales 27.27B 23.94B 22.04B 20.53B 38.73B 2,592B 39.51B 265B 103B 1,272B 102B 100B 4,429B 29.58B 25.97B 23.91B 22.28B 42.01B 2,812B 42.87B 288B 111B 1,381B 111B 109B 4,805B
Net income 4.84B 4.25B 3.92B 3.65B 6.88B 461B 7.02B 47.09B 18.25B 226B 18.19B 17.8B 787B 5.54B 4.87B 4.48B 4.17B 7.87B 527B 8.03B 53.89B 20.88B 259B 20.82B 20.37B 900B
Net Debt 8.83B 7.75B 7.13B 6.65B 12.54B 839B 12.79B 85.8B 33.24B 412B 33.14B 32.43B 1,434B 5.47B 4.8B 4.42B 4.12B 7.76B 520B 7.92B 53.14B 20.59B 255B 20.53B 20.08B 888B
Logo Stryker Corporation
Stryker Corporation is one of the world's leaders in designing, manufacturing and marketing medical equipment and devices in the fields of medical surgery, neurotechnology and orthopaedics. Net sales break down by family of products as follows: - surgical equipment and neurotechnology products (62.3%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipment, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (37.7%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2025, the group had 55 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (75.7%), Europe/Middle East/Africa (12.7%), Asia/Pacific (8.6%) and other (3%).
Employees
56,000
Date Price Change Volume
01/07/26 USD 310.13 -1.26% 4,682
30/06/26 USD 314.07 -6.03% 6,132
29/06/26 USD 334.21 +1.17% 712
26/06/26 USD 330.34 +3.92% 1,136
25/06/26 USD 317.88 +0.75% 995
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
313.39USD
Average target price
386.80USD
Spread / Average Target
+23.42%

Quarterly revenue - Rate of surprise